These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
439 related articles for article (PubMed ID: 27478374)
1. Inhaled corticosteroids can reduce osteoporosis in female patients with COPD. Liu SF; Kuo HC; Liu GH; Ho SC; Chang HC; Huang HT; Chen YM; Huang KT; Chen KY; Fang WF; Lin MC Int J Chron Obstruct Pulmon Dis; 2016; 11():1607-14. PubMed ID: 27478374 [TBL] [Abstract][Full Text] [Related]
2. Inhaled corticosteroids have a protective effect against lung cancer in female patients with chronic obstructive pulmonary disease: a nationwide population-based cohort study. Liu SF; Kuo HC; Lin MC; Ho SC; Tu ML; Chen YM; Chen YC; Fang WF; Wang CC; Liu GH Oncotarget; 2017 May; 8(18):29711-29721. PubMed ID: 28412726 [TBL] [Abstract][Full Text] [Related]
3. Effect of outpatient therapy with inhaled corticosteroids on decreasing in-hospital mortality from pneumonia in patients with COPD. Yamauchi Y; Yasunaga H; Hasegawa W; Sakamoto Y; Takeshima H; Jo T; Matsui H; Fushimi K; Nagase T Int J Chron Obstruct Pulmon Dis; 2016; 11():1403-11. PubMed ID: 27382276 [TBL] [Abstract][Full Text] [Related]
4. Post-inhaled corticosteroid pulmonary tuberculosis and pneumonia increases lung cancer in patients with COPD. Wu MF; Jian ZH; Huang JY; Jan CF; Nfor ON; Jhang KM; Ku WY; Ho CC; Lung CC; Pan HH; Wu MC; Liaw YP BMC Cancer; 2016 Oct; 16(1):778. PubMed ID: 27724847 [TBL] [Abstract][Full Text] [Related]
5. An evaluation of early medication use for COPD: a population-based cohort study. Falk J; Dik N; Bugden S Int J Chron Obstruct Pulmon Dis; 2016; 11():3101-3108. PubMed ID: 27994449 [TBL] [Abstract][Full Text] [Related]
6. Inhaled corticosteroids in COPD and the risk of lung cancer. Lee YM; Kim SJ; Lee JH; Ha E Int J Cancer; 2018 Nov; 143(9):2311-2318. PubMed ID: 29943812 [TBL] [Abstract][Full Text] [Related]
7. The association between inhaled corticosteroid and pneumonia in COPD patients: the improvement of patients' life quality with COPD in Taiwan (IMPACT) study. Wang CY; Lai CC; Yang WC; Lin CC; Chen L; Wang HC; Yu CJ Int J Chron Obstruct Pulmon Dis; 2016; 11():2775-2783. PubMed ID: 27877031 [TBL] [Abstract][Full Text] [Related]
8. Evaluating the association of osteoporosis with inhaled corticosteroid use in chronic obstructive pulmonary disease in Taiwan. Chiu KL; Lee CC; Chen CY Sci Rep; 2021 Jan; 11(1):724. PubMed ID: 33436973 [TBL] [Abstract][Full Text] [Related]
9. Increased risk of community-acquired pneumonia in COPD patients with comorbid cardiovascular disease. Lin SH; Perng DW; Chen CP; Chai WH; Yeh CS; Kor CT; Cheng SL; Chen JJ; Lin CH Int J Chron Obstruct Pulmon Dis; 2016; 11():3051-3058. PubMed ID: 27980402 [TBL] [Abstract][Full Text] [Related]
10. Effects of inhaled corticosteroids in monotherapy or combined with long-acting {beta}2-agonists on mortality among patients with chronic obstructive pulmonary disease. Cyr MC; Beauchesne MF; Lemière C; Aaron SD; Blais L Ann Pharmacother; 2010 Apr; 44(4):613-22. PubMed ID: 20233915 [TBL] [Abstract][Full Text] [Related]
11. Inhaled corticosteroids and risk of lung cancer among COPD patients who quit smoking. Kiri VA; Fabbri LM; Davis KJ; Soriano JB Respir Med; 2009 Jan; 103(1):85-90. PubMed ID: 18793832 [TBL] [Abstract][Full Text] [Related]
12. Use of Inhaled Corticosteroids and the Risk of Lung Cancer, the HUNT Study. Sørli K; Thorvaldsen SM; Hatlen P Lung; 2018 Apr; 196(2):179-184. PubMed ID: 29427221 [TBL] [Abstract][Full Text] [Related]
13. Combination therapy of inhaled steroids and long-acting beta2-agonists in asthma-COPD overlap syndrome. Lee SY; Park HY; Kim EK; Lim SY; Rhee CK; Hwang YI; Oh YM; Lee SD; Park YB Int J Chron Obstruct Pulmon Dis; 2016; 11():2797-2803. PubMed ID: 27877033 [TBL] [Abstract][Full Text] [Related]
14. "Real-life" inhaled corticosteroid withdrawal in COPD: a subgroup analysis of DACCORD. Vogelmeier C; Worth H; Buhl R; Criée CP; Lossi NS; Mailänder C; Kardos P Int J Chron Obstruct Pulmon Dis; 2017; 12():487-494. PubMed ID: 28203072 [TBL] [Abstract][Full Text] [Related]
15. Inhaled corticosteroids in COPD and onset of type 2 diabetes and osteoporosis: matched cohort study. Price DB; Voorham J; Brusselle G; Clemens A; Kostikas K; Stephens JW; Park HY; Roche N; Fogel R NPJ Prim Care Respir Med; 2019 Oct; 29(1):38. PubMed ID: 31659161 [TBL] [Abstract][Full Text] [Related]
16. Inhaled corticosteroids and the risks of low-energy fractures in patients with chronic airway diseases: A propensity score matched study. Tsai CH; Liao LY; Lin CL; Chung WS Clin Respir J; 2018 May; 12(5):1830-1837. PubMed ID: 29148205 [TBL] [Abstract][Full Text] [Related]
17. Effect of allergic phenotype on treatment response to inhaled bronchodilators with or without inhaled corticosteroids in patients with COPD. Cheng SL; Wang HH; Lin CH Int J Chron Obstruct Pulmon Dis; 2017; 12():2231-2238. PubMed ID: 28814851 [TBL] [Abstract][Full Text] [Related]
18. Inhaled corticosteroids and the risk of pneumonia in Medicare patients with COPD. Thornton Snider J; Luna Y; Wong KS; Zhang J; Chen SS; Gless PJ; Goldman DP Curr Med Res Opin; 2012 Dec; 28(12):1959-67. PubMed ID: 23098081 [TBL] [Abstract][Full Text] [Related]
19. Blood Eosinophil Counts, Withdrawal of Inhaled Corticosteroids and Risk of COPD Exacerbations and Mortality in the Clinical Practice Research Datalink (CPRD). Oshagbemi OA; Franssen FME; van Kraaij S; Braeken DCW; Wouters EFM; Maitland-van der Zee AH; Driessen JHM; de Vries F COPD; 2019 Apr; 16(2):152-159. PubMed ID: 31117850 [TBL] [Abstract][Full Text] [Related]
20. The importance of inhaler devices: the choice of inhaler device may lead to suboptimal adherence in COPD patients. Darbà J; Ramírez G; Sicras A; Francoli P; Torvinen S; Sánchez-de la Rosa R Int J Chron Obstruct Pulmon Dis; 2015; 10():2335-45. PubMed ID: 26604733 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]